Back to top
Rydex Series Fds, Biotechnology Fund Class A: (MF: RYBOX)
(NASDAQ Mutual Funds) As of May 30, 2024 08:00 PM ET
$62.77 USD
+0.82 (1.32%)
Zacks MF Rank
5-Strong Sell of 5 5
Latest Performance as of Apr 30, 2024
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | -6.63 | 88 |
| 3 months | -5.37 | 90 |
| 6 months | 11.99 | 90 |
| 1 Year | -0.70 | 89 |
| 3 Year | -5.36 | 89 |
| 5 Year | 3.40 | 91 |
| 10 Year | 5.97 | 92 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | NA |
| Bear Market (10/07 - 2/09) | -26.62 |
| Bull Market (2/09 - 3/21) | 569.88 |
Load Adjusted Returns as of Apr 30, 2024
| 1 Year | 4.09 |
| 5 Year | 2.82 |
| 10 Year | 5.66 |
| Since Inception | 10.14 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2024 | 0.73 | NA | NA | NA |
| 2023 | -2.25 | 0.03 | -3.89 | 12.58 |
| 2022 | -9.93 | -10.28 | -2.21 | 9.77 |
| 2021 | -1.61 | 10.01 | -3.23 | -3.03 |
| 2020 | -14.68 | 28.20 | 0.40 | 10.88 |
| 2019 | 18.38 | -3.70 | -8.55 | 19.59 |
Annual Return
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | -6.63 | 5.79 | -13.26 | 1.54 | 21.78 | 24.68 | -9.20 | 29.41 | -19.70 | 8.52 | 33.11 |
| % Total Return Rel to Index | -12.67 | -20.44 | 4.93 | -27.13 | 3.38 | -6.80 | -4.81 | 7.61 | -31.63 | 7.13 | 19.47 |
| % Total Return Rel to Peer | -8.64 | 0.03 | -3.85 | -7.13 | 0.51 | -1.99 | -9.32 | 7.29 | -8.92 | 1.09 | 7.44 |
| % Perf Quintile vs Peer* | 0.00 | 2.00 | 4.00 | 5.00 | 3.00 | 4.00 | 5.00 | 2.00 | 5.00 | 2.00 | 2.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 0.00 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 | 1.28 | 3.15 |
| Expense Ratio | 0.00 | 1.64 | 1.61 | 1.69 | 1.73 | 1.71 | 1.62 | 1.61 | 1.57 | 1.58 | 1.61 |
* 1 = Top 20%, 5 = Bottom 20%